Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.

This bill would change the Medicare prescription drug program (Part D) to require the companies that run these drug plans to include certain generic drugs and similar lower-cost versions of brand-name biological medicines on their list of covered medications. No official summary is available for this bill.

Your Vote